Treatment Approach for Children with ADHD and Mood Disorders
For children with both ADHD and mood disorders, treatment should include FDA-approved medications for ADHD combined with evidence-based behavioral therapy, with careful assessment and treatment of the mood disorder as a critical component of the management plan. 1
Assessment and Diagnosis
- Comprehensive evaluation must include screening for comorbid conditions, particularly mood disorders (depression, anxiety, bipolar disorder) 1
- Use validated rating scales to document baseline symptoms from multiple sources (parents, teachers)
- Assess for other potential comorbidities:
- Behavioral: oppositional defiant disorder, conduct disorders, substance use
- Developmental: learning/language disorders, autism spectrum disorders
- Physical: tics, sleep apnea 1
Treatment Algorithm
Step 1: Determine Age and Prioritize Treatment Targets
Ages 4-5 years:
- First-line: Evidence-based parent/teacher-administered behavior therapy
- Second-line: Consider methylphenidate if behavior therapy is insufficient 1
Ages 6-11 years:
- Combination of FDA-approved ADHD medications AND evidence-based behavioral therapy 1
- Address mood symptoms concurrently
Ages 12-18 years:
- FDA-approved medications for ADHD with adolescent assent
- Behavioral therapy recommended 1
- Screen for substance use before initiating treatment
Step 2: Medication Selection
For ADHD Component:
First-line medications (strongest evidence):
- Stimulants (methylphenidate, amphetamine-based medications) 1
- Titrate doses to achieve maximum benefit with minimum side effects
Second-line medications (if stimulants contraindicated or ineffective):
For Mood Component:
- For depression/anxiety with ADHD:
- Consider atomoxetine as it may improve both ADHD symptoms and depressive symptoms 2
- For more severe mood symptoms, specific treatment for the mood disorder may be necessary
Step 3: Behavioral Interventions
- Parent training in behavior management
- Classroom behavioral interventions
- Educational supports (IEPs or 504 plans)
- Skills development targeting organization and time management 3
Monitoring and Follow-up
- Regular monitoring of:
- Vital signs, weight, appetite, sleep quality
- Height (in children)
- Emergence of tics or psychiatric adverse reactions
- Response to treatment for both ADHD and mood symptoms
Important Considerations and Pitfalls
- Children with anxiety and ADHD respond well to both behavioral and pharmacological ADHD treatments 4
- Treatment of ADHD may help prevent development of future psychiatric disorders 4
- Common pitfalls to avoid:
- Inadequate dose titration
- Ignoring timing of medication administration
- Overlooking behavioral interventions
- Neglecting comorbid mood disorders
- Discontinuing treatment prematurely 3
- Treating only the ADHD while ignoring mood symptoms
Special Considerations
- Children with ADHD and mood disorders may show slower improvement with atomoxetine compared to those with ADHD only, but can still achieve significant benefit 2
- The presence of comorbid mood disorders complicates diagnosis, treatment, and prognosis of ADHD, requiring careful monitoring and adjustment of the treatment plan 4
- Fluoxetine monotherapy has shown promise in some children with ADHD and comorbid non-bipolar mood disorders, improving both depressive symptoms and ADHD symptoms 5
Remember that ADHD is a chronic condition requiring ongoing management following principles of the chronic care model, with regular follow-up and treatment adjustments as needed 1.